The Food and Drug Administration on Tuesday granted accelerated approval for Biogen’s drug tofersen, which treats a rare and aggressive form of the disease known as ALS. Accelerated approval is an F… [+4106 chars]Read More
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease CNBC
